E06.1 - From topology to disease and back

E06.1 - From topology to disease and back

🎙 Malte Spielmann 👥 4K 📅 December 1, 2025 ⏱ 46 min 👁 131 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

TADenhancer hijackingposition effectstructural variantsingle-cell RNA-seq

Summary

In this educational session, Dr. Malte Spielmann discusses the role of 3D genome architecture in disease, focusing on structural variants that affect topologically associating domains (TADs). He begins by highlighting the diagnostic gap in whole-genome sequencing, where many variants fall in non-coding regions. He explains how TAD boundaries and enhancer-promoter interactions are crucial for proper gene regulation. Using examples from his own research, he demonstrates how deletions, inversions, and duplications can disrupt TAD boundaries, leading to enhancer hijacking and misexpression of genes, causing diseases such as limb malformations and leukodystrophy. He presents unpublished work on a novel deletion upstream of LMNB1 that causes a distinct form of leukodystrophy via enhancer hijacking, validated in mouse models with single-cell RNA-seq. He also discusses a case of a translocation causing a severe bone disorder and a potential role for coding mutations in HMGB1 affecting chromatin folding. The talk concludes with a call for integrating 3D genome analysis into clinical diagnostics.

157 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the emerging field of 3D genome architecture in disease. The speaker presents a compelling argument for considering non-coding structural variants in diagnostics, supported by concrete examples from his research. The argumentation is logical and builds from basic principles to complex cases, making it accessible yet technically rich. The inclusion of unpublished data adds novelty but also limits the ability to fully evaluate the claims.

Scientific Rigor, Source Quality, Title Accuracy

The speaker cites several key papers in the field, including the landmark 100,000 Genomes Project pilot and his own publications on TAD boundary deletions. The sources are relevant and credible. The title accurately reflects the content, which bridges basic science and clinical application. The talk is well-structured and the speaker clearly explains complex concepts.

139 words

Title / Content Match

The title accurately reflects the content, which explores how 3D genome topology influences disease and how disease can inform our understanding of topology.

Quality & Reliability

8/10

The talk is given by a leading expert in the field, presenting both established knowledge and unpublished research. The content is well-structured and based on published studies, but as a conference presentation, it lacks the formal peer-review process of a journal article.

Key Moments

Cited Sources

  • Gillissen et al. (2014) Genome sequencing identifies major causes of severe intellectual disability — Cited as a landmark paper that achieved ~60% diagnostic yield in severe intellectual disability using whole-genome sequencing.
  • 100,000 Genomes Project Pilot — Cited for a diagnostic yield of 35% in rare disease.
  • Lupiáñez et al. (2015) Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions — Cited as the first demonstration that TAD boundary deletions cause disease via enhancer hijacking.
  • Giorgio et al. (2021) A novel insertion causing enhancer hijacking in a severe bone disorder — Cited for the case of a translocation causing a severe bone disorder.

Concurring Sources

Dissenting Sources

  • Some researchers argue that TADs are not always essential for gene regulation — There is debate about the functional importance of TADs in all contexts, with some studies suggesting that enhancer-promoter interactions can occur across TAD boundaries.

Contribution & Novelties

This talk provides a comprehensive overview of how structural variants affecting 3D genome architecture can cause disease, with a focus on enhancer hijacking. It presents unpublished data on a novel deletion upstream of LMNB1 that causes a distinct form of leukodystrophy via enhancer hijacking, validated in mouse models. The use of single-cell RNA-seq to dissect cell-type-specific effects is a novel approach. The talk also highlights the importance of considering non-coding variants in clinical diagnostics.

Pour aller plus loin :

110 words

Radar Profile

The radar profile shows high scores in quality of information and technical level, reflecting the speaker's expertise and the advanced content. The quantity of information is also high, but the global reliability is slightly lower due to the inclusion of unpublished data and the format of a conference talk.

Reliability 8/10

💬 No comments were provided for analysis.